Rakuten Medical To Present At The 40th Annual J.P. Morgan Healthcare Conference On January 10th, 2022

Published by
The Street

By PR Newswire SAN DIEGO, Jan. 5, 2022 /PRNewswire/ — Rakuten Medical, Inc. (RMI), a global biotechnology company developing precision-targeted cancer therapies based on its proprietary, anti-cancer treatment platform, Illuminox™, will present at the 40th Annual J.P. Morgan Healthcare Conference being held virtually January 10-13, 2022. Rakuten Medical’s Vice Chairman and CEO, Mickey Mikitani, is scheduled to present virtually at approximately 10:30am PST, Monday, January 10. A live audio webcast of the presentation can be accessed by following this link. Following the completion of the prese…

Read More

Leave a Reply